Reliability and Validity of iscorEB (Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa).
| Author | |
|---|---|
| Abstract | :
Epidermolysis bullosa (EB) is a group of rare and currently incurable genetic blistering disorders. As more pathogenic driven therapies are being developed, the need for EB-specific validated outcomes measures designed for use in clinical trials is becoming important. |
| Year of Publication | :
2018
|
| Journal | :
The British journal of dermatology
|
| Date Published | :
2018
|
| ISSN Number | :
0007-0963
|
| URL | :
http://dx.doi.org/10.1111/bjd.16350
|
| DOI | :
10.1111/bjd.16350
|
| Short Title | :
Br J Dermatol
|
| Download citation |